Skip to main content

Semaglutide May Lower Risk for Opioid Overdose in T2DM, Opioid Use Disorder

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 25, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Sept. 25, 2024 -- For patients with type 2 diabetes (T2D) and opioid use disorder (OUD), semaglutide is associated with a significantly lower risk for opioid overdose compared with other antidiabetic medications, according to a research letter published online Sept. 25 in JAMA Network Open.

William Wang, from the Case Western Reserve University School of Medicine in Cleveland, and colleagues conducted an emulation target trial to compare the association of semaglutide versus other antidiabetic medications with opioid overdose risk among patients with comorbid T2D and OUD. The study included 33,006 eligible patients: 3,034 prescribed semaglutide and 29,972 prescribed other antidiabetic medications.

The researchers found that during one-year follow-up, semaglutide was associated with a significantly lower risk for opioid overdose compared with other antidiabetic medications, including other glucagon-like peptide 1 receptor agonists, with hazard ratios varying from 0.32 to 0.58. No difference between the groups was seen in the negative control outcome (medical encounters for congenital malformations, deformations, and chromosomal abnormalities).

"Semaglutide was associated with reduced opioid overdose risk in patients with comorbid T2D and OUD, suggesting its potential therapeutic value for preventing overdoses," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted September 2024

Read this next

Less 'Experienced Weight Stigma' After Bariatric Surgery Aids Mental Health

FRIDAY, June 6, 2025 -- Experienced weight stigma (EWS) improves from pre- to post-metabolic bariatric surgery (MBS), according to a study published online June 5 in Health...

Obesity Linked to Subsequent Neoplasms in Childhood Cancer Survivors

FRIDAY, June 6, 2025 -- Body mass index (BMI) and physical activity are associated with the risk for subsequent neoplasms among childhood cancer survivors, according to a study...

GLP-1 Receptor Agonist Exposure Linked to Neovascular AMD in Patients With Diabetes

FRIDAY, June 6, 2025 -- For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased risk for incident neovascular...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.